Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 3/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29870054 | 1.00 | CYP19A1 (0.46) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL9929156 | 0.91 | CYP19A1 (0.42) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL4193242 | 0.91 | CYP19A1 (0.47) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL9861856 | 0.90 | CYP19A1 (0.45) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL16569927 | 0.87 | CYP3A4 (0.40) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL7630201 | 0.87 | CYP19A1 (0.39) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL7035972 | 0.87 | KDM4E (0.50) | CYP19A1ALDH1A1KDM4EMEN1GAA | |
| SCHEMBL28851984 | 0.83 | CYP19A1 (0.50) | CYP19A1ALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL738593 | 0.81 | ALDH1A1 (0.44) | CYP19A1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL20494555 | 0.79 | CYP19A1 (0.47) | CYP19A1ALDH1A1KDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114653344-A | Triazole gel material, preparation method thereof and application of triazole gel material in adsorption of organic pollutants | 中山大学 | 2022-06-24 | — | — | CN | claimed |
| CN-107298756-B | Alkyne-anthracene/aryl copolymer and preparation method thereof | 安徽理工大学 | 2020-06-26 | — | — | CN | claimed |
| US-20140194605-A1 | SERS Reporter Molecules and Methods | CABOT SECURITY MATERIALS, INC. (US) | 2014-07-10 | — | — | US | claimed |
| US-20120156491-A1 | SERS Reporter Molecules and Methods | CABOT SECURITY MATERIALS INC. (US) | 2012-06-21 | — | — | US | claimed |
| US-4097460-A | DIPHENYLACETYLENE, DIPHENYLBUTADIYNE, MOLDING MATERIALS FOR HIGH TEMPERATURE APPLICATIONS | HERCULES INCORPORATED (US) | 1978-06-27 | — | — | US | claimed |
| US-4070333-A | AROMATIZATION CATALYST, ADDITION POLYMERIZATION | HERCULES INCORPORATED (US) | 1978-01-24 | — | — | US | claimed |
| JP-3064323-A | — | — | None | — | — | JP | disclosed |
| CN-118054082-A | Nonaqueous electrolyte additive, nonaqueous electrolyte containing same and secondary battery | 蜂巢能源科技股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-11548984-B2 | Light- or heat-curing method and curable resin composition | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-110678500-B | Photo-or thermosetting method and curable resin composition | 富士胶片和光纯药株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-114653344-A | Triazole gel material, preparation method thereof and application of triazole gel material in adsorption of organic pollutants | 中山大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-108602955-B | Photocuring method, compound used in photocuring method, and composition | 富士胶片和光纯药株式会社 | 2021-08-06 | — | — | CN | disclosed |
| US-10774062-B2 | Photocuring method, compound and composition used therein | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| US-4097460-A | DIPHENYLACETYLENE, DIPHENYLBUTADIYNE, MOLDING MATERIALS FOR HIGH TEMPERATURE APPLICATIONS | HERCULES INCORPORATED (US) | 1978-06-27 | — | — | US | disclosed |
| US-4070333-A | AROMATIZATION CATALYST, ADDITION POLYMERIZATION | HERCULES INCORPORATED (US) | 1978-01-24 | — | — | US | disclosed |
| US-4026859-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026860-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026861-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-3993711-A | THERMOSETTING RESINS; COUPLING AGENTS; CARBOXYLATED PREPOLYMER | HERCULES INCORPORATED (US) | 1976-11-23 | — | — | US | disclosed |
| US-3931093-A | CURING | HERCULES INCORPORATED (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194605-A1 | SERS Reporter Molecules and Methods | SRRT, MYCBP, SPR | CYP19A1 2524/4885ALDH1A1 194/4885KDM4E 3497/4885 |
| US-10774062-B2 | Photocuring method, compound and composition used therein | ESD, TMT1A, PAM | CYP19A1 2246/4885ALDH1A1 23/4885KDM4E 1162/4885 |
| US-20120156491-A1 | SERS Reporter Molecules and Methods | SRRT, MYCBP, SPR | CYP19A1 2524/4885ALDH1A1 194/4885KDM4E 3497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.